Systemic Immune-Inflammation Index Tied to Mortality in CKD

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 24, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Sept. 24, 2024 -- There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in patients with chronic kidney disease (CKD), according to a study published online Sept. 10 in Immunity, Inflammation and Disease.

Meng Jia, from the Shanghai University of Traditional Chinese Medicine, and colleagues investigated the association between SII and all-cause mortality in individuals with CKD. The analysis included 9,303 people with CKD participating in the National Health and Nutrition Examination Survey (1999 to 2018).

The researchers found that during a median follow-up of 86 months, there was a distinctive J-shaped relationship between SII level and all-cause mortality. The nadir was seen at an SII level of 478.93 in the second quartile. The risk for all-cause mortality increased per increment of one standard deviation of SII once SII exceeded 478.93 (hazard ratio, 1.13). There was an association between elevated SII and an increased risk for all-cause mortality among patients with CKD (quartile 4 versus quartile 2: hazard ratio, 1.23). The correlation between SII and CKD mortality was particularly pronounced for participants older than 60 years and for individuals with diabetes. When removing the extreme 5 percent outliers of SII, there was a linear positive association between SII and all-cause mortality.

"The SII index, encompassing platelet, neutrophil, and lymphocyte counts, offers a more comprehensive representation of the equilibrium between inflammatory status and host immune response," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords